592 related articles for article (PubMed ID: 24016855)
1. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
[TBL] [Abstract][Full Text] [Related]
2. Facilitated nanoscale delivery of insulin across intestinal membrane models.
Woitiski CB; Sarmento B; Carvalho RA; Neufeld RJ; Veiga F
Int J Pharm; 2011 Jun; 412(1-2):123-31. PubMed ID: 21501675
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
Rekha MR; Sharma CP
J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
[TBL] [Abstract][Full Text] [Related]
4. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
[TBL] [Abstract][Full Text] [Related]
5. Efficient mucus permeation and tight junction opening by dissociable "mucus-inert" agent coated trimethyl chitosan nanoparticles for oral insulin delivery.
Liu M; Zhang J; Zhu X; Shan W; Li L; Zhong J; Zhang Z; Huang Y
J Control Release; 2016 Jan; 222():67-77. PubMed ID: 26686663
[TBL] [Abstract][Full Text] [Related]
6. Comparative study of Pluronic(®) F127-modified liposomes and chitosan-modified liposomes for mucus penetration and oral absorption of cyclosporine A in rats.
Chen D; Xia D; Li X; Zhu Q; Yu H; Zhu C; Gan Y
Int J Pharm; 2013 Jun; 449(1-2):1-9. PubMed ID: 23583840
[TBL] [Abstract][Full Text] [Related]
7. Enhancing insulin oral absorption by using mucoadhesive nanoparticles loaded with LMWP-linked insulin conjugates.
Sheng J; He H; Han L; Qin J; Chen S; Ru G; Li R; Yang P; Wang J; Yang VC
J Control Release; 2016 Jul; 233():181-90. PubMed ID: 27178809
[TBL] [Abstract][Full Text] [Related]
8. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
[TBL] [Abstract][Full Text] [Related]
9. Bioinspired butyrate-functionalized nanovehicles for targeted oral delivery of biomacromolecular drugs.
Wu L; Liu M; Shan W; Zhu X; Li L; Zhang Z; Huang Y
J Control Release; 2017 Sep; 262():273-283. PubMed ID: 28774842
[TBL] [Abstract][Full Text] [Related]
10. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
[TBL] [Abstract][Full Text] [Related]
11. N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption.
Sheng J; Han L; Qin J; Ru G; Li R; Wu L; Cui D; Yang P; He Y; Wang J
ACS Appl Mater Interfaces; 2015 Jul; 7(28):15430-41. PubMed ID: 26111015
[TBL] [Abstract][Full Text] [Related]
12. Polyglutamic Acid Functionalization of Chitosan Nanoparticles Enhances the Therapeutic Efficacy of Insulin Following Oral Administration.
Urimi D; Agrawal AK; Kushwah V; Jain S
AAPS PharmSciTech; 2019 Feb; 20(3):131. PubMed ID: 30815757
[TBL] [Abstract][Full Text] [Related]
13. Enhanced oral absorption and anticancer efficacy of cabazitaxel by overcoming intestinal mucus and epithelium barriers using surface polyethylene oxide (PEO) decorated positively charged polymer-lipid hybrid nanoparticles.
Ren T; Wang Q; Xu Y; Cong L; Gou J; Tao X; Zhang Y; He H; Yin T; Zhang H; Zhang Y; Tang X
J Control Release; 2018 Jan; 269():423-438. PubMed ID: 29133120
[TBL] [Abstract][Full Text] [Related]
14. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
Makhlof A; Tozuka Y; Takeuchi H
Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
[TBL] [Abstract][Full Text] [Related]
15. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
[TBL] [Abstract][Full Text] [Related]
16. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
Fan W; Xia D; Zhu Q; Li X; He S; Zhu C; Guo S; Hovgaard L; Yang M; Gan Y
Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
[TBL] [Abstract][Full Text] [Related]
17. Calcium depletion-mediated protease inhibition and apical-junctional-complex disassembly via an EGTA-conjugated carrier for oral insulin delivery.
Chuang EY; Lin KJ; Su FY; Chen HL; Maiti B; Ho YC; Yen TC; Panda N; Sung HW
J Control Release; 2013 Aug; 169(3):296-305. PubMed ID: 23195534
[TBL] [Abstract][Full Text] [Related]
18. Combination therapy via oral co-administration of insulin- and exendin-4-loaded nanoparticles to treat type 2 diabetic rats undergoing OGTT.
Chuang EY; Nguyen GT; Su FY; Lin KJ; Chen CT; Mi FL; Yen TC; Juang JH; Sung HW
Biomaterials; 2013 Oct; 34(32):7994-8001. PubMed ID: 23891516
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological effect of orally delivered insulin facilitated by multilayered stable nanoparticles.
Woitiski CB; Neufeld RJ; Veiga F; Carvalho RA; Figueiredo IV
Eur J Pharm Sci; 2010 Nov; 41(3-4):556-63. PubMed ID: 20800679
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive imaging oral absorption of insulin delivered by nanoparticles and its stimulated glucose utilization in controlling postprandial hyperglycemia during OGTT in diabetic rats.
Chuang EY; Lin KJ; Su FY; Mi FL; Maiti B; Chen CT; Wey SP; Yen TC; Juang JH; Sung HW
J Control Release; 2013 Dec; 172(2):513-22. PubMed ID: 23702234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
